We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Image: The updated framework is intended for use in molecular diagnostic reports, tumor board discussions, clinical guidelines, and routine treatment planning (Image Credit: Shutterstock)

Updated Framework Guides Assessment of Actionable Cancer Biomarkers

ESMO has updated its ESCAT framework to help oncologists assess molecular alterations and match patients with targeted therapies. More...
27 Oct 2026
Image Credit: Adobe Stock

Genomic Tissue Test Predicts Metastasis and Abiraterone Benefit in High-Risk Prostate Cancer

A tissue-based molecular test stratifies prostate cancer spread risk and identifies patients who may benefit from therapy.

More...
27 Oct 2026
Photo courtesy of Tempus AI

RNA Sequencing Assay Gains EU Certification for Solid Tumor Profiling

The Tempus xR assay has received certification under the EU’s IVDR as a Class C in vitro diagnostic device. More...
27 Oct 2026
Image Credit: Adobe Stock

Decentralized Laboratory Network Improves Detection of Viral Hemorrhagic Fevers in Guinea

New findings show that sustained decentralized laboratories enable 24-hour viral hemorrhagic fever testing. More...
27 Oct 2026
Image: New research shows that human lung cancers use a process called alternative RNA splicing to produce different versions (isoforms) of the immune-alarm gene STAT2, shown here as ribbons. Isoforms of STAT2 are associated with how well lung cancer patients respond to immunotherapy: an isoform that retains an extra segment called an intron (top ribbon) is found in patients who respond to anti-PD-L1, while an isoform without it (bottom ribbon) is found in nonresponders. These splicing signatures could one day help doctors predict, before treatment begins, which patients are most likely to benefit from immunotherapy. (Photo courtesy of The Jackson Laboratory)

Lung Tumor RNA Variants Offer Clues to Immunotherapy Benefit

Researchers identify gene activity patterns linked to immunotherapy response in lung cancer. More...
27 Oct 2026
Image: Spleen tissue from a mouse without PHF19 (left) and a mouse with normal PHF19 function (right). Dense clusters of immune cells sit within blood-rich regions in pink. Without PHF19, cells are altered in their differentiation process (Photo courtesy of Gianni Gamarra/Centro de Regulación Genómica)

Six-Gene Score Improves Prognosis Prediction in Acute Myeloid Leukemia

Researchers identify a six-gene AML score that more accurately predicts survival and may simplify prognostic testing. More...
26 Oct 2026
Image Credit: iStock

Long-Read Sequencing Reveals Cancer-Driving Changes Missed by Conventional Testing

Long-read sequencing reveals hidden cancer-driving changes missed by conventional methods, offering a clearer view of tumor genetics. More...
26 Oct 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
HPV Test
Allplex HPV28 Detection
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Copyright © 2000-2026 Globetech Media. All rights reserved.